Grisofulvin Suspension
Product Images NDC 69097-361

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Grisofulvin (NDC 69097-361). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cipla Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

883762d6 5d17 4ccd 99e6 254a6ad208ef 01

Chemical structure diagram of grisofulvin showing the molecular formula C17H17ClO6 and molecular weight 352.77. The structure depicts the arrangement of atoms and functional groups characteristic of the active ingredient grisofulvin.*

FDA Label Image

883762d6 5d17 4ccd 99e6 254a6ad208ef 02

Label for Griseofulvin Oral Suspension USP (microsize) 125 mg/5 mL by Cipla USA Inc. The label states it is an oral suspension with a 4 fl oz (120 mL) container. It includes dosage information, tamper-resistant seal warning, storage instructions, and manufacturer details, with a barcode and area designated for batch overprinting.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.